MicroBioGen wins 2020 CCBJ Business Achievement Award for COVID Resilience & Business Growth.
MicroBioGen has a new look
We are excited to reveal our brand new logo and website.
Novozymes launches a super robust, non-GM yeast (Innova® Fit) in the US
Innova® Fit is the fourth launch from the Innova® platform, which has quickly become the industry benchmark.
MicroBioGen wins the Australian Export Awards
MicroBioGen wins the Minerals, Energy and Related Services division of the 57th Australian Export Awards.
MicroBioGen wins the NSW Export Awards
MicroBioGen wins the Minerals, Energy and Related Services section of the Premier’s NSW Export Awards.
Novozymes launches the next yeast in the Innova® platform developed by MicroBioGen
Novozymes Announcement: Innova® Fit is the first fully non-GM yeast that will initially be sold in South America. The CEO of Novozymes made the following comments about the Innova yeast platform on the Investor call on the 8th of August 2019. “I think it is maybe not fully appreciated that we have actually grown a very significant yeast market and been very successful in the yeast market in the US and expect that these launches will continue to enable growth in the yeast market in the US so this is not a zero sum game or even a negative game, even if volumes go down, it is a plus game because we are really, really adding a lot of successful innovation to the yeast space.”
Novozymes launches its next product in the Yeast platform developed in conjunction with MicroBioGen
Novozymes announcement: The next generation yeast is Innova® Force.
MicroBioGen uses the directed evolution of yeast to solve the problem of producing lignocellulosic bioethanol at industrial scale.
Novozymes launches Innova® Lift – Second yeast biocatalyst product in collaboration with MicroBioGen.
MicroBioGen named finalist at the NSW Export Awards
MicroBioGen named finalist in the NSW International Development category.
Novozymes launches Innova® Drive – First yeast biocatalyst product in collaboration with MicroBioGen.
MicroBioGen receives A$4M ARENA grant for optimisation of Gen II Yeast Biocatalysts.